fbpx
QQQ
-2.71
348.05
-0.78%
DIA
-5.86
344.51
-1.73%
SPY
-7.07
429.04
-1.68%
TLT
+ 2.69
140.35
+ 1.88%
GLD
-0.87
166.72
-0.52%

Curaleaf Q1 Revenue Comes In At $75.1M

May 31, 2019 11:08 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Curaleaf Q1 Revenue Comes In At $75.1M

Cannabis operator Curaleaf Holdings, Inc. (CSE:CURA)(OTC:CURLF) reported first quarter revenue of $75.1 million, a year-to-year increase of 260 percent.

Curaleaf opened seven new dispensaries in key markets such as Florida, Maryland and New York, building on existing licenses and prior acquisitions.

Curaleaf recently acquired Select, a cannabis wholesale brand; It completed the acquisition of exclusive rights to operate Absolute Healthcare's Emerald dispensary in Arizona; And the company also completed the acquisition of Eureka Investment Partners in California.

"We reported strong organic growth, anchored by our core East Coast markets, and announced several landmark transactions, including the acquisition of Select, that will position Curaleaf to lead the industry forward,” said CEO Joseph Lusardi in a press release.

“The combination of Curaleaf and Select will bring together the largest retailer and largest wholesaler, with the leading wellness and lifestyle brands in the United States, providing substantial opportunities to accelerate revenue growth, achieve significant cost savings and expand overall margins."

Curaleaf's stock traded at $8.25 per share at time of publication.

Related Links:

Curaleaf To Buy 'Select' Brand Owner Cura Partners In $948M Deal

Curaleaf Signs Agreement To Acquire Eureka Investment Partners

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to our YouTube channel.


Related Articles

The Week In Cannabis: Federal Research Bill, George Lopez, Brazil, Morocco, Columbia Care And More

As we near the end of the first half of 2021, we can see cannabis stocks traded mostly up by double digits, with the Amplify Seymour Cannabis ETF (NYSE: CNBS) delivering gains of more than 50% year-to-date. This week, however, stocks posted mixed performances. read more

TerrAscend To Benefit From M&A Activity, Reports Strong Q1 Results, 106% YoY Increase In Net Sales, Strong Cash Balance

TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) reported Wednesday its financial results for the first quarter of 2021, highlighting a substantial cash balance of $234 million. In the first three months of the fiscal year, net sales amounted to $53.4 million, up by 106% year-over-year. read more

Agrify's Shares Jump On 600% YoY Higher Revenue Of $7M, Cannabis Co. Raises Its Full-Year Guidance

A developer of premium grow solutions, Agrify Corporation (NASDAQ: AGFY) posted its first-quarter earnings results Monday, reporting revenue of $7 million, compared to $4.4 million and $1 million in the previous quarter and the same quarter of 2020, respectively. read more

The Week In Cannabis: Trulieve's $2.1B Acquisition, New ETF, Earnings, Federal Legalization And More

In a week of big M&A news and mixed earnings reports, cannabis stocks traded mostly down. read more